Investigational Site Number : 3920001

Nagoya, Aichi-ken 467-8602

0 studies enrolling now · 2 studies all time

What they study most

Plasma Cell Myeloma, Plasma Cell Myeloma Recurrent

Studies at this site

• SC Versus IV Isatuximab in Combination With Pomalidomide and Dexamethasone in RRMM — Running, not enrolling
• Multinational Clinical Study Comparing Isatuximab, Pomalidomide, and Dexamethasone to Pomalidomide and Dexamethasone in Refractory or Relapsed and Refractory Multiple Myeloma Patients — Completed